KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Opko Health (OPK) Invested Capital (2016 - 2025)

Historic Invested Capital for Opko Health (OPK) over the last 16 years, with Q3 2025 value amounting to $1.3 billion.

  • Opko Health's Invested Capital fell 694.35% to $1.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 billion, marking a year-over-year decrease of 694.35%. This contributed to the annual value of $1.4 billion for FY2024, which is 255.66% down from last year.
  • As of Q3 2025, Opko Health's Invested Capital stood at $1.3 billion, which was down 694.35% from $1.3 billion recorded in Q2 2025.
  • Opko Health's Invested Capital's 5-year high stood at $1.8 billion during Q3 2021, with a 5-year trough of $1.3 billion in Q1 2024.
  • For the 5-year period, Opko Health's Invested Capital averaged around $1.5 billion, with its median value being $1.6 billion (2023).
  • In the last 5 years, Opko Health's Invested Capital soared by 984.15% in 2021 and then plummeted by 1906.84% in 2024.
  • Over the past 5 years, Opko Health's Invested Capital (Quarter) stood at $1.7 billion in 2021, then dropped by 6.16% to $1.6 billion in 2022, then dropped by 11.2% to $1.4 billion in 2023, then dropped by 2.56% to $1.4 billion in 2024, then decreased by 4.49% to $1.3 billion in 2025.
  • Its Invested Capital was $1.3 billion in Q3 2025, compared to $1.3 billion in Q2 2025 and $1.3 billion in Q1 2025.